YGEIA3 LTD

Company Registration Number:
11607738 (England and Wales)

Unaudited statutory accounts for the year ended 31 October 2025

Period of accounts

Start date: 1 November 2024

End date: 31 October 2025

YGEIA3 LTD

Contents of the Financial Statements

for the Period Ended 31 October 2025

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

YGEIA3 LTD

Directors' report period ended 31 October 2025

The directors present their report with the financial statements of the company for the period ended 31 October 2025

Principal activities of the company

The principal activity of YgEia3 is the provision of scientific wellness testing and related health and performance services. The company provides laboratory testing and analysis of biomarkers, vitamins, minerals, nutritional status and other health-related indicators. The company also provides testing and analytical services to individuals, businesses, healthcare professionals and sports organisations, together with related products and services designed to support health, wellness and performance. During the year, the company continued to develop its laboratory, testing capabilities and sports-related services and maintained its focus on providing reliable scientific testing and analysis to its customers.

Company policy on disabled employees

YgEia3 is committed to providing equal opportunities for all employees and prospective employees. The company does not discriminate against employees or applicants on the grounds of disability. Where an employee becomes disabled during their employment, the company will consider reasonable adjustments to their role, working arrangements or workplace to support them in continuing their employment wherever practicable. Recruitment, training, promotion and development opportunities are based on an individual's skills, experience and suitability for the role.

Additional information

During July 2025, the company completed the sale of its business to SHUAAA Private Health Equity. The transaction represented a significant change in the company's ownership and structure. Following completion of the sale, the company has continued to manage the remaining matters arising from the transaction, including the completion of final payments to some shareholders. The directors consider the transaction to be a significant event in the company’s development and believe that the company is well positioned for its future activities.



Directors

The director shown below has held office during the whole of the period from
1 November 2024 to 31 October 2025

Scott McLaughlin

The directors shown below have held office during the period of
1 November 2024 to 7 July 2025

Disa Sanstorn
 Kelly Whitman
 Edward Keith

The director shown below has held office during the period of
7 July 2025 to 31 October 2025

Kinnick

Secretary Duncan Spence

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
25 July 2026

And signed on behalf of the board by:
Name: Kinnick
Status: Director

YGEIA3 LTD

Profit And Loss Account

for the Period Ended 31 October 2025

2025 2024


£
£
Turnover: 14,500,000 5,750,000
Cost of sales: ( 2,500,000 ) ( 5,850,000 )
Gross profit(or loss): 12,000,000 (100,000)
Distribution costs: ( 275,000 ) ( 250,000 )
Administrative expenses: ( 5,000 ) ( 4,500 )
Other operating income: 9,900,000 4,500,000
Operating profit(or loss): 21,620,000 4,145,500
Interest receivable and similar income: 78,500 7,895
Interest payable and similar charges: ( 125,000 ) ( 285,000 )
Profit(or loss) before tax: 21,573,500 3,868,395
Tax: ( 124,500 ) ( 84,500 )
Profit(or loss) for the financial year: 21,449,000 3,783,895

YGEIA3 LTD

Balance sheet

As at 31 October 2025

Notes 2025 2024


£
£
Fixed assets
Investments: 3 99,785,469 75,000,000
Total fixed assets: 99,785,469 75,000,000
Current assets
Debtors: 4 50,000 2,000,000
Cash at bank and in hand: 99,895,648 97,250,000
Investments: 5 99,999,999 47,500,000
Total current assets: 199,945,647 146,750,000
Net current assets (liabilities): 199,945,647 146,750,000
Total assets less current liabilities: 299,731,116 221,750,000
Creditors: amounts falling due after more than one year: 6 ( 1,500,000 ) ( 2,500,000 )
Total net assets (liabilities): 298,231,116 219,250,000
Capital and reserves
Called up share capital: 98,500,000 97,500,000
Share premium account: 99,500,000 22,000,000
Other reserves: 250,000
Profit and loss account: 99,981,116 99,750,000
Total Shareholders' funds: 298,231,116 219,250,000

The notes form part of these financial statements

YGEIA3 LTD

Balance sheet statements

For the year ending 31 October 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 6 August 2026
and signed on behalf of the board by:

Name: Kinnick
Status: Director

The notes form part of these financial statements

YGEIA3 LTD

Notes to the Financial Statements

for the Period Ended 31 October 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

YGEIA3 LTD

Notes to the Financial Statements

for the Period Ended 31 October 2025

  • 2. Employees

    2025 2024
    Average number of employees during the period 21 96

YGEIA3 LTD

Notes to the Financial Statements

for the Period Ended 31 October 2025

3. Fixed assets investments note

The company’s fixed asset investments are stated at cost less any provision for impairment. At the balance sheet date, the directors reviewed the carrying value of the company’s investments and considered that there was no material impairment requiring recognition in the financial statements. Where the company holds investments in subsidiary or associated undertakings, these are included at cost less accumulated impairment losses.

YGEIA3 LTD

Notes to the Financial Statements

for the Period Ended 31 October 2025

4. Debtors

2025 2024
£ £
Other debtors 50,000 2,000,000
Total 50,000 2,000,000

YGEIA3 LTD

Notes to the Financial Statements

for the Period Ended 31 October 2025

5. Current assets investments note

he company’s current asset investments are stated at fair value where this can be measured reliably. Any changes in the value of current asset investments are recognised in the profit and loss account. At the balance sheet date, the directors reviewed the company’s current asset investments and considered their carrying value to be appropriate.

YGEIA3 LTD

Notes to the Financial Statements

for the Period Ended 31 October 2025

6. Creditors: amounts falling due after more than one year note

2025 2024
£ £
Other creditors 1,500,000 2,500,000
Total 1,500,000 2,500,000